Skip to main content
Log in

Benign tyrosinaemia: an 18-year follow-up

  • Case Reports
  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Endo F, Kitano A, Uehara I et al (1983) 4-Hydroxyphenylpyruvic acid oxidase deficiency with normal fumaryl-acetoacetase: a new variant form of hereditary hypertyrosinemia.Pediatr Res 17: 92–96.

    PubMed  CAS  Google Scholar 

  • Endo F, Jatho H, Yamando S et al (1991) A murine model for type III tyrosinemia. Lack of immunologically detectable 4-hydroxyphenylpyruvate dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.Am J Hum Genet 48: 704–709.

    PubMed  CAS  Google Scholar 

  • Giardini O, Catani A, Kennaway NG et al (1983) Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.Pediatr Res 17: 25–29.

    PubMed  CAS  Google Scholar 

  • Lindstedt S, Holme E, Lock EA et al (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.Lancet 340: 813–817.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoppoloni, G., Santinelli, R., Prisco, F. et al. Benign tyrosinaemia: an 18-year follow-up. J Inherit Metab Dis 18, 641–642 (1995). https://doi.org/10.1007/BF02436013

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02436013

Keywords

Navigation